Loading clinical trials...
Loading clinical trials...
Randomized Blinded Clinical Trial to Evaluate the Safety and Efficacy of Arnica Tincture in the Topical Treatment of Cutaneous Leishmaniasis.
Conditions
Interventions
Arnica Tincture
Meglumine antimoniate.
Locations
1
Colombia
Grupo de Investigación Clínica PECET (GIC-PECET)
Medellín, Antioquia, Colombia
Start Date
October 1, 2025
Primary Completion Date
December 1, 2026
Completion Date
February 1, 2029
Last Updated
February 14, 2025
NCT06917040
NCT06695143
NCT03969134
NCT04888130
NCT04841239
NCT01641796
Lead Sponsor
Universidad de Antioquia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions